SCHEMBL23309596

SCHEMBL23309596

COc1ccccc1OC(=O)c1cc(F)nc(F)c1F

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 3/20 0.51
▸ POLB P06746 2/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ KMT2A Q03164 5/20 0.49
▸ MEN1 O00255 3/20 0.49
▸ SMN1; SMN2 Q16637 4/20 0.42
▸ ESR1 P03372 2/20 0.41
▸ PRSS1 P07477 1/20 0.41
▸ ACR P10323 1/20 0.41
▸ ESR2 Q92731 1/20 0.41
▸ NPSR1 Q6W5P4 1/20 0.41
▸ NPC1 O15118 2/20 0.40
▸ LMNA P02545 2/20 0.40
▸ HTT P42858 2/20 0.40
▸ KDM4E B2RXH2 1/20 0.40
▸ PAX8 Q06710 1/20 0.40
▸ RAB9A P51151 1/20 0.40
▸ TSHR P16473 1/20 0.38
▸ HPGD P15428 1/20 0.38
▸ XBP1 P17861 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23309606 0.80 SMN1; SMN2 (0.38) POLBALDH1A1KMT2AMEN1SMN1; SMN2
SCHEMBL23309607 0.80 MAPT (0.49) MAPTPOLBALDH1A1KMT2AMEN1
SCHEMBL23309657 0.80 TSHR (0.51) MAPTPOLBALDH1A1KMT2AMEN1
SCHEMBL23309619 0.77 NPC1 (0.40) MAPTALDH1A1SMN1; SMN2NPSR1NPC1
SCHEMBL23309616 0.74 ALDH1A1 (0.49) MAPTPOLBALDH1A1KMT2AMEN1
SCHEMBL31321657 0.73 ESR1 (0.66) MAPTPOLBALDH1A1KMT2AMEN1
SCHEMBL23309497 0.72 KMT2A (0.57) MAPTPOLBALDH1A1KMT2AMEN1
SCHEMBL10493708 0.72 KMT2A (0.62) MAPTPOLBALDH1A1KMT2AMEN1
SCHEMBL23309649 0.71 HTT (0.46) MAPTKMT2AMEN1SMN1; SMN2NPSR1
SCHEMBL23309544 0.70 TSHR (0.48) MAPTALDH1A1KMT2AMEN1NPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210120817-A1 PLANT DISEASE CONTROL AGENT MEIJI SEIKA PHARMA CO., LTD. (JP) 2021-04-29 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210120817-A1 PLANT DISEASE CONTROL AGENT BROX, ALG1, CTRL MAPT 1126/4885POLB 1411/4885ALDH1A1 2033/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback